Back to COGT

Elmind Capital, LP → COGT

Elmind Capital, LP COGT Position History

Cogent Biosciences, Inc. • Healthcare

Quarters held
4
Latest value
$27.8M
Q3 2026
Peak value
$45.3M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$41.6M
Q1 2026$45.1M
Q2 2026$45.3M
Q3 2026$27.8M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$27.8M866.7K——
Q2 2026$45.3M1.17M——
Q1 2026$45.1M1.17M——
Q4 2025$41.6M1.17M——

Other funds holding COGT

Other Elmind Capital, LP positions

SNDX

SYNDAX PHARMACEUTICALS INC

$43.3M
SNDX

SYNDAX PHARMACEUTICALS INC

$40.6M
SNDX

SYNDAX PHARMACEUTICALS INC

$39M
CLDX

CELLDEX THERAPEUTICS INC NEW

$36.8M
CLDX

CELLDEX THERAPEUTICS INC NEW

$36M
LEGN

LEGEND BIOTECH CORP

$31.2M
SNDX

SYNDAX PHARMACEUTICALS INC

$30.2M
CLDX

CELLDEX THERAPEUTICS INC NEW

$27.4M